A detailed history of Janus Henderson Group PLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 3,588,571 shares of LNTH stock, worth $276 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
3,588,571
Previous 3,331,549 7.71%
Holding current value
$276 Million
Previous $267 Million 47.24%
% of portfolio
0.21%
Previous 0.15%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$77.7 - $123.62 $20 Million - $31.8 Million
257,022 Added 7.71%
3,588,571 $394 Million
Q2 2024

Aug 14, 2024

SELL
$58.87 - $83.05 $29.9 Million - $42.2 Million
-507,655 Reduced 13.22%
3,331,549 $267 Million
Q1 2024

May 15, 2024

SELL
$51.07 - $68.26 $5.53 Million - $7.4 Million
-108,367 Reduced 2.75%
3,839,204 $239 Million
Q4 2023

Feb 14, 2024

BUY
$55.6 - $77.89 $47.7 Million - $66.8 Million
857,421 Added 27.75%
3,947,571 $245 Million
Q3 2023

Nov 14, 2023

BUY
$60.27 - $90.75 $131 Million - $198 Million
2,179,640 Added 239.39%
3,090,150 $215 Million
Q2 2023

Aug 14, 2023

BUY
$82.41 - $99.65 $28.8 Million - $34.9 Million
349,906 Added 62.42%
910,510 $76.4 Million
Q1 2023

May 15, 2023

BUY
$47.76 - $82.86 $23.9 Million - $41.4 Million
499,488 Added 817.28%
560,604 $46.3 Million
Q4 2022

Feb 14, 2023

BUY
$48.76 - $77.67 $2.38 Million - $3.78 Million
48,711 Added 392.67%
61,116 $3.11 Million
Q3 2022

Nov 14, 2022

SELL
$61.42 - $86.29 $72,168 - $101,390
-1,175 Reduced 8.65%
12,405 $872,000
Q2 2022

Aug 15, 2022

SELL
$55.54 - $72.65 $833 - $1,089
-15 Reduced 0.11%
13,580 $897,000
Q1 2022

May 16, 2022

BUY
$24.28 - $56.64 $48 - $113
2 Added 0.01%
13,595 $752,000
Q4 2021

Feb 14, 2022

BUY
$22.54 - $30.44 $306,386 - $413,770
13,593 New
13,593 $393,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.28B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.